Home The Friedewald Formula Underestimates LDL Cholesterol at low Concentrations
Article
Licensed
Unlicensed Requires Authentication

The Friedewald Formula Underestimates LDL Cholesterol at low Concentrations

  • Hubert Scharnagl , Matthias Nauck , Heinrich Wieland and Winfried März
Published/Copyright: June 1, 2005
Become an author with De Gruyter Brill
Clinical Chemistry and Laboratory Medicine (CCLM)
From the journal Volume 39 Issue 5

Abstract

Due to recent advances in the treatment of hypercholesterolemia, low density lipoprotein (LDL) cholesterol concentrations below 2.6 mmol/l have become attainable. In general, LDL cholesterol is determined indirectly according to Friedewald. We examined the performance of the Friedewald formula at low concentrations of LDL cholesterol in comparison with a β-quantification method. We analyzed 176 samples from individuals treated by LDL apheresis with a mean LDL cholesterol concentration of 3.07 mmol/l and found that the Friedewald formula underestimated LDL cholesterol with a bias of −18.5%, −14.5%, −7.3%, and −3.8% at mean LDL cholesterol levels of 1.58, 2.4, 3.49, and 4.67 mmol/l, respectively. Thus, the lower the LDL cholesterol concentration was, the greater the negative bias. We conclude that the Friedewald formula may not be reliable at low LDL cholesterol concentrations produced by LDL apheresis. This finding may also be of relevance to the monitoring of patients being treated with lipid lowering drugs.

:
Published Online: 2005-06-01
Published in Print: 2001-06-06

Copyright © 2001 by Walter de Gruyter GmbH & Co. KG

Articles in the same Issue

  1. SIBioC 2001 33rd National Congress of the Italian Society of Clinical Biochemistry and Clinical Molecular Biology
  2. CCLM: The Near Future
  3. Granulocyte-Colony Stimulating Factor and Macrophage-Colony Stimulating Factor in Patients with Non-Small-Cell Lung Cancer
  4. Circulating Matrix Metalloproteinases and Their Inhibitors in Premature Coronary Atherosclerosis
  5. Real-Time Quantitative Reverse Transcriptase-Polymerase Chain Reaction (RT-PCR) for the Measurement of Prostate-Specific Antigen mRNA in the Peripheral Blood of Patients with Prostate Carcinoma Using the TaqManTM Detection System
  6. Serum Cardiac Troponin I after Conventional and Minimal Invasive Coronary Artery Bypass Surgery
  7. Improvement of the Quantitative Method for Glucose Determination Using Hexokinase and Glucose 6-Phosphate Dehydrogenase
  8. Conditions for Single-Strand Conformation Polymorphism (SSCP) Analysis of BRCA1 Gene Using an Automated Electrophoresis Unit
  9. Discrepancies between Apolipoprotein E Phenotyping and Genotyping in the Elderly
  10. Markers of Bone Turnover in Postmenopausal Women Receiving Hormone Replacement Therapy
  11. Reference Intervals for the Markers of Proteinuria with a Standardised Bed-Rest Collection of Urine
  12. The Friedewald Formula Underestimates LDL Cholesterol at low Concentrations
  13. The White Blood Cell Differential: Three Methods Compared
  14. Plasma Brain Natriuretic Peptide Measured by Fully-Automated Immunoassay and by Immunoradiometric Assay Compared
  15. Length of Sedimentation Reaction in Undiluted Blood (Erythrocyte Sedimentation Rate): Variations with Sex and Age and Reference Limits
  16. Biochemical Analysis of the Sperm and Infertility
  17. Evaluation of a Rapid Bedside Immunochromatographic Assay for Detection of Cardiac Troponin I in Whole Blood
  18. Correct Graphic Presentation of Method Comparison Data
  19. European Symposium on Clinical Laboratory and In Vitro Diagnostics Industry
Downloaded on 7.11.2025 from https://www.degruyterbrill.com/document/doi/10.1515/CCLM.2001.068/html
Scroll to top button